Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
D000284:Administration, Oral; D000527:Alprostadil; D015232:Dinoprostone; D004305:Dose-Response Relationship, Drug; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D010100:Oxygen / Q000097:blood; D011458:Prostaglandins E / Q000009:adverse effects / Q000627:therapeutic use*
D011458:Prostaglandins E; D000527:Alprostadil; D015232:Dinoprostone; D010100:Oxygen